Literature DB >> 2746588

Primary antiphospholipid syndrome.

D Alarcón-Segovia1, J Sanchez-Guerrero.   

Abstract

An antiphospholipid antibody (APLA) syndrome has been proposed for those patients with systemic lupus erythematosus (SLE) or with other connective tissue diseases who have APLA and manifestations that seem related to their effect (venous thrombosis, arterial occlusions, thrombocytopenia, hemolytic anemia, recurrent fetal loss, leg ulcers, and livedo reticularis). Occurrence of a primary antiphospholipid syndrome has also been mentioned but not defined. We present 9 young patients who had at least 2 of the clinical manifestations that have been related to high titers of APLA, but had neither SLE nor other recognizable connective tissue disease. We propose criteria for diagnosis of such a primary antiphospholipid syndrome and discuss the possible mechanisms whereby a single autoantibody can cause systemic disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746588

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  39 in total

1.  Optimising testing for phospholipid antibodies.

Authors:  M Helbert; S Bodger; J Cavenagh; D D'Cruz; J M Thomas; P MacCallum
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 2.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 3.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

4.  Prevalence of anticardiolipin antibodies in the elderly British population.

Authors:  K K Chakravarty; R E Gray; M Webley; M A Byron; J Wozniak
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

5.  Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome.

Authors:  J Ordi-Ros; J Villarreal; F Monegal; S Sauleda; I Esteban; M Vilardell
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 6.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

7.  Antimitochondrial antibodies in the antiphospholipid syndrome.

Authors:  N Abuaf; S Laperche; R Carsique; O Meyer; A Deschamps; B Rajoely; C Johanet; J C Homberg
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

8.  Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

Authors:  N Di Simone; P L Meroni; N de Papa; E Raschi; D Caliandro; C S De Carolis; M A Khamashta; T Atsumi; G R Hughes; G Balestrieri; A Tincani; P Casali; A Caruso
Journal:  Arthritis Rheum       Date:  2000-01

Review 9.  Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature.

Authors:  J M Durand; P Lefevre; G Kaplanski; P Casanova; J Soubeyrand
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

10.  Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology.

Authors:  E Toussirot; D Figarella-Branger; P Disdier; J R Harle; P J Weiller
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.